Cargando…
Menthol Enhances an Antiproliferative Activity of 1α,25-Dihydroxyvitamin D(3) in LNCaP Cells
1α,25-dihydroxyvitamin D(3) [1α,25(OH)(2)D(3)], the most active form of vitamin D(3), and its analogues have therapeutic benefits for prostate cancer treatment. However, the development of hypercalcemia is an obstacle to clinical applications of 1α,25(OH)(2)D(3) for cancer therapy. In this study, we...
Autores principales: | Park, Eun-Jung, Kim, Su-Hwa, Kim, Byung-Joo, Kim, Sung-Young, So, Insuk, Jeon, Ju-Hong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654468/ https://www.ncbi.nlm.nih.gov/pubmed/19308266 http://dx.doi.org/10.3164/jcbn.08-201 |
Ejemplares similares
-
Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells
por: Wang, Wei-Lin W, et al.
Publicado: (2011) -
Anti-Cancer Effect of Lambertianic Acid by Inhibiting the AR in LNCaP Cells
por: Lee, Myoung-Sun, et al.
Publicado: (2016) -
ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors
por: Gustavsson, Heléne, et al.
Publicado: (2010) -
Effect of CD133 overexpression on bone metastasis in prostate cancer cell line LNCaP
por: Sohn, Hong Moon, et al.
Publicado: (2019) -
Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: ZHANG, XIANQING, et al.
Publicado: (2014)